Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

Summary

Background Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with hepatitis B but only level II evidence in patients with cirrhosis. This lack of randomized data has spurred questions regarding the utility of HCC surveillance in this patient population; however, lack of randomized data does not equate to a lack of data supporting the efficacy of surveillance. The aim of our study was to determine the effect of HCC surveillance on early stage tumor detection, receipt of curative therapy, and overall survival in patients with cirrhosis. Methods and Findings We performed a systematic literature review using Medline from January 1990 through January 2014 and a search of national meeting abstracts from 2009–2012. Two investigators identified studies that reported rates of early stage tumor detection, curative treatment receipt, or survival, stratified by HCC surveillance status, among patients with cirrhosis. Both investigators independently extracted data on patient populations, study methods, and results using standardized forms. Pooled odds ratios, according to HCC surveillance status, were calculated for each outcome using the DerSimonian and Laird method for a random effects model. We identified 47 studies with 15,158 patients, of whom 6,284 (41.4%) had HCC detected by surveillance. HCC surveillance was associated with improved early stage detection (odds ratio [OR] 2.08, 95% CI 1.80–2.37) and curative treatment rates (OR 2.24, 95% CI 1.99–2.52). HCC surveillance was associated with significantly prolonged survival (OR 1.90, 95% CI 1.67–2.17), which remained significant in the subset of studies adjusting for lead-time bias. Limitations of current data included many studies having insufficient duration of follow-up to assess survival and the majority not adjusting for liver function or lead-time bias. Conclusions HCC surveillance is associated with significant improvements in early tumor detection, receipt of curative therapy, and overall survival in patients with cirrhosis.

Related articles

• Cancer detection in clinical practice and using blood-based liquid biopsy: A retrospective audit of over 350 dogs

  This article presents a retrospective audit of cancer detection methods in dogs, particularly focusing on the effectiveness of blood-based liquid biopsy as a tool for early detection during routine wellness visits. It evaluates the rates at which cancer was diagnosed in a cohort of client-owned dogs and compares them against current standard care practices.

• Temporal reasoning with medical data - A review with emphasis on medical natural language processing

  This document reviews the significance and challenges of processing temporal information in medical narrative data, emphasizing the intersection between temporal reasoning and medical natural language processing. It discusses theoretical frameworks, methodologies, and the need for more research in this domain.

• Endocrine Disorders

  This document provides an overview of the endocrine system, detailing the anatomy and functions of various glands, hormones released, and diagnostic tests related to endocrine disorders.

• NCM 116: CARE OF CLIENTS WITH NEUROLOGIC DISORDERS (ALTERATION IN PERCEPTION)

  This document serves as an outline for a course on the care of clients with neurologic disorders, focusing on the nervous system's structure, functions, and endocrine disorders as they relate to patient care.

• Fish Diseases and Their Management in Aquaculture

  This document provides comprehensive insights into various fish diseases, their environmental conditions, and management strategies relevant to aquaculture. It covers issues related to temperature stratification, oxygen depletion, and different viral infections affecting fish health.